A hot new trend strutted down Wall Street toward the end of last year under the banner of quantum computing stocks. These ...
Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire ...
As of 20 February 2025, the index has steadily increased, rising 14.41% in the last 12 months and 4.21% year to date in 2025.
Exclusive: Mass General Brigham’s Gene and Cell Therapy Institute is partnering with Cambridge biotech Cellino to create the ...
In a separate agreement, Quest will provide lab services for end-stage kidney disease and specialized water testing for Fresenius and its partners.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback